HuGE Literature Finder
Records 1-7
A mutational signature associated with alcohol consumption and prognostically significantly mutated driver genes in esophageal squamous cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology 2018 Jan . Li X C, Wang M Y, Yang M, Dai H J, Zhang B F, Wang W, Chu X L, Wang X, Zheng H, Niu R F, Zhang W, Chen K |
Genetic Features of Aflatoxin-associated Hepatocellular Carcinomas.
Gastroenterology 2017 Mar . Zhang Weilong, He Huan, Zang Mengya, Wu Qifeng, Zhao Hong, Lu Ling-Ling, Ma Peiqing, Zheng Hongwei, Wang Nengjin, Zhang Ying, He Siyuan, Chen Xiaoyan, Wu Zhiyuan, Wang Xiaoyue, Cai Jianqiang, Liu Zhihua, Sun Zongtang, Zeng Yi-Xin, Qu Chunfeng, Jiao Yuch |
Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma.
Epidemiology (Cambridge, Mass.) 2013 Sep 24 (5): 671-81. Long Xi-Dai, Zhao Dong, Wang Chao, Huang Xiao-Ying, Yao Jin-Guang, Ma Yun, Wei Zhong-Hua, Liu Min, Zeng Li-Xiao, Mo Xiao-Qiang, Zhang Jian-Jun, Xue Feng, Zhai Bo, Xia Qia |
Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Genomics 2013 Aug 102 (2): 74-83. Tornesello Maria Lina, Buonaguro Luigi, Tatangelo Fabiana, Botti Gerardo, Izzo Francesco, Buonaguro Franco |
Somatic changes in primary liver cancer in Russia: a pilot study.
Mutation research 2013 Aug 755 (2): 90-9. Kalinina Olga, Marchio Agnès, Urbanskii Aleksandr I, Tarkova Aleksandra B, Rebbani Khadija, Granov Dmitri A, Dejean Anne, Generalov Mikhail I, Pineau Pasc |
Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis.
PloS one 2012 7 (6): e37707. Villar Stephanie, Ortiz-Cuaran Sandra, Abedi-Ardekani Behnoush, Gouas Doriane, Nogueira da Costa Andre, Plymoth Amelie, Khuhaprema Thiravud, Kalalak Anant, Sangrajrang Suleeporn, Friesen Marlin D, Groopman John D, Hainaut Pier |
Impact of TP53 codon 72 and MDM2 promoter 309 allelic dosage in a Moroccan population with hepatocellular carcinoma.
The International journal of biological markers 0 26 (4): 229-33. Ezzikouri Sayeh, Essaid El Feydi Abdellah, Afifi Rajae, Benazzouz Mustapha, Hassar Mohammed, Pineau Pascal, Benjelloun Souma |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: